[PDF][PDF] Expression of PD/PD-L1 as a prognostic bio-marker in ovarian serous carcinoma carcinoma-A

AM Gashi, B Elshani, H Latifi, G Sopa, JIA Sherifi - immunity, 2022 - researchgate.net
Ovarian cancer has the highest mortality rate of any gynecologic malignancy other. Even
after optimal treatment, the prognosis remains poor. To date, no biomarker can predict the …

Clinical and cultural conflicts

J Sherifi - British Journal of General Practice, 2017 - bjgp.org
By some accident of genealogy, I recently found myself flying to an Arabian Gulf state to act
as the next-of-kin and surrogate advocate for a relative who had suffered a catastrophic brain …

Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery

J Cheng, BA Teply, I Sherifi, J Sung, G Luther, FX Gu… - Biomaterials, 2007 - Elsevier
Nanoparticle (NP) size has been shown to significantly affect the biodistribution of targeted
and non-targeted NPs in an organ specific manner. Herein we have developed NPs from …

[HTML][HTML] PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells

A Boire, L Covic, A Agarwal, S Jacques, S Sherifi… - Cell, 2005 - cell.com
Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that
play critical roles in thrombosis, inflammation, and vascular biology. PAR1 is proposed to be …

GP appraisal: an evaluation of generational differences on the utility of GP appraisal

K Hopayian, J Sherifi - Education for Primary Care, 2020 - Taylor & Francis
Background A number of studies have previously been published on the benefits of GP
appraisal. Ours is the first study that compares the views of doctors registered before and after …

The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules

BA Teply, R Tong, SY Jeong, G Luther, I Sherifi… - Biomaterials, 2008 - Elsevier
Protein drugs have low bioavailability after oral administration, which is due in part to fast
transit of the drugs or drug delivery vehicles through the gastrointestinal tract. Increasing the …

Whither mortality

J Sherifi - British Journal of General Practice, 2010 - bjgp.org
I am unsure as to what constitutes a normal lifespan in current day UK. I no longer know
when a person is considered to be old enough to have died of ‘old age’or ‘natural causes’ or …

[BOOK][B] General Practice Under the NHS: Past, Present and Future

J Sherifi - 2022 - taylorfrancis.com
… James Sherifi, the author, having succumbed to polio as an infant, subsequently developed
a lifelong vocation to be a doctor, a dream realised when he graduated from Dundee …

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

…, J Cheng, BA Teply, I Sherifi… - Proceedings of the …, 2006 - National Acad Sciences
Targeted uptake of therapeutic nanoparticles in a cell-, tissue-, or disease-specific manner
represents a potentially powerful technology. Using prostate cancer as a model, we report …

Seroprevalence of canine leishmaniosis in asymptomatic dogs in Kosovo

B Xhekaj, J Stefanovska, K Sherifi, A Rexhepi… - Parasitology …, 2023 - Springer
Canine leishmaniosis (CanL) is a neglected zoonotic disease caused by Leishmania spp.
Leishmania infantum is the species responsible for the zoonotic form of the disease where …